Replimune Correlations
| REPL Stock | USD 8.39 0.25 2.89% |
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Replimune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Replimune Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Replimune Correlation With Market
Excellent diversification
The correlation between Replimune Group and DJI is -0.59 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and DJI in the same portfolio, assuming nothing else is changed.
Replimune | Build AI portfolio with Replimune Stock |
Moving together with Replimune Stock
Moving against Replimune Stock
| 0.8 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.68 | GXEA | Galapagos NV | PairCorr |
| 0.63 | VALN | Valneva SE ADR | PairCorr |
| 0.56 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.48 | DNLI | Denali Therapeutics Earnings Call This Week | PairCorr |
| 0.43 | CMB | Cambium Bio Earnings Call This Week | PairCorr |
| 0.42 | 2CG | NANOSPHERE HEASCIENCES | PairCorr |
| 0.41 | EQ | Equillium | PairCorr |
| 0.83 | DRTS | Alpha Tau Medical | PairCorr |
| 0.77 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.75 | 0P6S | Bayer AG NA | PairCorr |
| 0.53 | AVH | Avita Medical | PairCorr |
| 0.43 | H2K2 | XTL Biopharmaceuticals Split | PairCorr |
| 0.41 | PYC | Physiomics Plc | PairCorr |
| 0.36 | PHARM | Pharming Group NV | PairCorr |
| 0.34 | DSGN | Design Therapeutics | PairCorr |
| 0.76 | ALA | Arovella Therapeutics Earnings Call This Week | PairCorr |
| 0.73 | SRZNW | Surrozen Warrant | PairCorr |
| 0.64 | DVAX | Dynavax Technologies | PairCorr |
| 0.53 | VNDA | Vanda Pharmaceuticals Trending | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Replimune Stock performing well and Replimune Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Replimune's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| KLDO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| IVBT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| XENO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CALA | 24.24 | 7.70 | 0.10 | (0.84) | 20.48 | 100.00 | 280.00 | |||
| NMRD | 1.49 | (0.69) | 0.00 | 0.62 | 0.00 | 0.00 | 50.00 | |||
| SYVC | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SNNAQ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| FPMI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Replimune Corporate Management
| Colin Love | Chief Officer | Profile | |
| Christopher Sarchi | Chief Officer | Profile | |
| Carolyn Trott | Senior Assurance | Profile | |
| Pamela Esposito | Chief Business Officer | Profile | |
| Paul Bullock | Chief Head | Profile | |
| Kari Jeschke | Senior Affairs | Profile |